Study Site — Miami, Florida

Study Site is a clinical research site located in Miami, Florida, United States 33101.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 17 clinical trials.

Therapeutic areas: Type 2 Diabetes, Schizophrenia, Factor XIII Deficiency.

Sponsors: Better Therapeutics, Otsuka Pharmaceutical Development & Commercialization, Inc., Intarcia Therapeutics.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 17 clinical trials on record. Their work covers Type 2 Diabetes, Schizophrenia, Factor XIII Deficiency.

Is Study Site accredited by Crixeo Health?

Yes — Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.